GSK: Antibody treatment works against Omicron
GlaxoSmithKline plc said on Thursday that preclinical data showed that its COVID-19 antibody treatment sotrovimab “retains activity against key mutations of the Omicron variant.”
“Sotr…
Harry T. Partner's Academy & fpmarkets
NOI SIAMO UN GRUPPO DI LAVORO PER QUESTO NON TI CHIEDIAMO SOLDI. CON NOI NON SARAI SOLO
